The Cleveland Cavaliers are facing a challenging offseason as point guard Darius Garland has become a focal point of trade rumors. However, his recent toe surgery, announced on June 9, 2025, has put his future with the team in question.
- Darius Garland rumored as trade candidate.
- Underwent surgery for toe injury.
- Expected recovery by training camp start.
- Likely to miss start of regular season.
- Averaged 20.6 points in recent season.
- Effective lead guard when healthy.
According to ESPN’s Shams Charania, Garland will be sidelined for approximately four to five months following the procedure. While the Cavaliers are optimistic about his recovery, there are concerns he may miss the start of the regular season, which could impact potential trade scenarios.
Garland’s impressive performance last season, where he averaged 20.6 points and helped the Cavs achieve a 64-18 record, makes him a valuable asset. Will teams still pursue him despite his injury? This situation is certainly worth monitoring.
The uncertainty surrounding Garland’s health could reshape the Cavaliers’ offseason strategy. With his ability to lead an offense, teams may still show interest, but his recovery timeline complicates matters.
- Garland averaged 20.6 points and 6.7 assists last season.
- He played a key role in the Cavs’ top Eastern Conference finish.
- His injury could impact trade negotiations this summer.
- Garland’s recovery is crucial for the Cavs’ upcoming season.
